|
Orthologous residues
|
|
VASP (human): S239‑p, VASP (mouse): S235‑p, VASP (rat): S236‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
platelet-blood, PtK2 (epithelial)
|
|
Cellular systems studied:
cell lines, primary cells
|
|
Species studied:
human, rat
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
PGI2
|
|
|
|
increase
|
|
|
SNP
|
|
|
|
increase
|
|
|
5 6-DCl-cBIMPS
|
|
|
|
increase
|
|
|
cGMP analog
|
|
|
|
increase
|
|
|
PGE1
|
|
|
|
increase
|
|
|